Drug Database
Back to search

United States· US:49281-725_07174da3-a257-4ad4-8ad4-0e90bbb6f9e8

FLUBLOK TRIVALENT NORTHERN HEMISPHERE

A medicinal product containing influenza a virus a/district of columbia/27/2023 (h3n2) recombinant hemagglutinin antigen; influenza a virus a/west virginia/30/2022 (h1n1) recombinant hemagglutinin antigen; influenza b virus b/austria/1359417/2021 recombinant hemagglutinin antigen, registered in United States by Sanofi Pasteur Inc..

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFLUBLOK TRIVALENT NORTHERN HEMISPHEREATC—REGISTER NO.US:49281-725_07174da3…PACKS LISTED2CHECKEDJune 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about influenza a virus a/district of columbia/27/2023 (h3n2) recombinant hemagglutinin antigen; influenza a virus a/west virginia/30/2022 (h1n1) recombinant hemagglutinin antigen; influenza b virus b/austria/1359417/2021 recombinant hemagglutinin antigenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
INFLUENZA A VIRUS A/DISTRICT OF COLUMBIA/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN
Manufacturer
Sanofi Pasteur Inc.
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 26, 2026

Packs & prices · 2

  • ndc11
    4928172510
    10 SYRINGE in 1 CARTON (49281-725-10) / .5 mL in 1 SYRINGE (49281-725-88)
  • ndc11
    49281-725-10

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d88944dd-37b8-4585-9cd0-b889b356e90e
GET /v1/drugs/d88944dd-37b8-4585-9cd0-b889b356e90e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAMUSCULAR",
  "source": "ndc",
  "strength": "45; 45; 45",
  "substance": "INFLUENZA A VIRUS A/DISTRICT OF COLUMBIA/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN",
  "productndc": "49281-725",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "ug/.5mL; ug/.5mL; ug/.5mL",
  "application_number": "BLA125285",
  "marketing_category": "BLA"
}
API referenceMCP serverPlans

See everything about influenza a virus a/district of columbia/27/2023 (h3n2) recombinant hemagglutinin antigen; influenza a virus a/west virginia/30/2022 (h1n1) recombinant hemagglutinin antigen; influenza b virus b/austria/1359417/2021 recombinant hemagglutinin antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console